Autonomix Medical (AMIX) closed at $0.89 on November 20, 2026, down 14.3% from the previous close, on volume of 181,520 shares (30-day average 2,336,216).
Data as of November 20, 2026.
Autonomix Medical Updates Corporate Presentation Under Regulation FD
TipRanks (Fri, 20-Nov 8:29 AM ET)
Globe Newswire (Thu, 12-Nov 8:30 AM ET)
Globe Newswire (Tue, 10-Nov 2:30 PM ET)
Globe Newswire (Fri, 2-Oct 8:05 AM ET)
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
Globe Newswire (Wed, 30-Sep 8:30 AM ET)
Globe Newswire (Thu, 24-Sep 8:30 AM ET)
Globe Newswire (Wed, 16-Sep 8:30 AM ET)
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
Globe Newswire (Tue, 1-Sep 8:30 AM ET)
Globe Newswire (Wed, 26-Aug 8:30 AM ET)
Market Chameleon (Tue, 25-Aug 3:05 AM ET)
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
Autonomix Medical trades on the NASDAQ stock market under the symbol AMIX.
As of November 20, 2026, AMIX stock price declined to $0.89 with 181,520 million shares trading.
AMIX has a beta of 4.39, meaning it tends to be more sensitive to market movements. AMIX has a correlation of 0.13 to the broad based SPY ETF.
AMIX has a market cap of $1.82 million. This is considered a Sub-Micro Cap stock.
AMIX has underperformed the market in the last year with a price return of -95.3% while the SPY ETF gained +5.2%. AMIX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -84.9% and -41.4%, respectively, while the SPY returned -10.1% and -5.9%, respectively.
AMIX support price is $.94 and resistance is $1.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMIX shares will trade within this expected range on the day.